Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation

Clinical trial NCT06905054 · RECRUITING

Trial details

NCT number: NCT06905054
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Sclerosing Cholangitis Liver Transplant, Complications PSC Biliary Strictures

Start date: 2025-04-15
Primary completion: 2028-03-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.